Abstract
e22516Background: Although 3-year imatinib adjuvant therapy is recommended by the guidelines, there is a lack of the data in clinical practice regarding use of adjuvant therapy and adherence. A pro...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have